Form 4 for CDNA CareDx, Inc.
Accepted 2025-02-07 00:00:00 ET · period of report 2025-02-05 · accession 0001931277-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-07 | 2025-02-05 | CDNA | Jain Abhishek | CFO | A - Grant | $0.00 | +37.8K | 292.1K | +15% | $0 | |
| 2025-02-07 | 2025-02-05 | CDNA | Jain Abhishek | CFO | F - Tax | $23.32 | -9,989 | 282.1K | -3% | -$232.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-05 | A | A | 37,800 | $0.00 | 292,092 | D | — | — | (F1) The reported securities were subject to a performance restricted stock unit award that was initially granted on February 1, 2023 for a two-year performance period over calendar years 2023 and 2024, which performance was assessed and finalized on February 1, 2025. 50.00% of the reported securities vested on February 1, 2025, but were not delivered until February 5, 2025. 50.00% of the reported securities will vest on February 1, 2026, subject to the Reporting Person's continued service with the Issuer. |
| 2 | Common | Common Stock | 2025-02-05 | F | D | 9,989 | $23.32 | 282,103 | D | — | — | (F2) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of performance restricted stock units. |